Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Aug 15, 2023
Date Accepted: Oct 20, 2023

The final, peer-reviewed published version of this preprint can be found here:

Usability and Efficacy of Artificial Intelligence Chatbots (ChatGPT) for Health Sciences Students: Protocol for a Crossover Randomized Controlled Trial

Veras M, Omer Dyer J, Rooney M, Barros Silva PG, Rutherford D, Kairy D

Usability and Efficacy of Artificial Intelligence Chatbots (ChatGPT) for Health Sciences Students: Protocol for a Crossover Randomized Controlled Trial

JMIR Res Protoc 2023;12:e51873

DOI: 10.2196/51873

PMID: 37999958

PMCID: 10709780

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Crossover Randomized Controlled Trial to Evaluate the Efficacy and Usability of Artificial Intelligence Chatbots (ChatGPT) for Health Sciences Students (AIHSS) in Canada

  • Mirella Veras; 
  • Joseph Omer Dyer; 
  • Morgan Rooney; 
  • Paulo Goberlânio Barros Silva; 
  • Derek Rutherford; 
  • Dahlia Kairy

ABSTRACT

Background:

The integration of Artificial Intelligence (AI) into health science students' education holds significant importance. AI in education may impact critical thinking leading to unintended consequences that need to be addressed. Understanding the implications of AI adoption in education is essential for ensuring its responsible and effective use, empowering health science students to navigate AI-driven technologies' evolving field with essential knowledge and skills.

Objective:

This study aims to investigate the usability and effectiveness of ChatGPT, a large language model (LLM) model, as a supplementary assistance tool for enhancing learning outcomes among undergraduate health science students focusing on chronic diseases.

Methods:

Crossover Randomized Controlled Trial, single-blind. Participants will be allocated to Group A and Group B in a 1:1 ratio using computer-generated randomization. Fifty students will be recruited for this study. The alternative hypothesis posits that there will be a significant difference in learning outcomes and technology usability between students utilizing ChatGPT (Group A) and those using standard online tools (Group B) to access resources and complete assignments.

Results:

This research aims to understand the potential benefits and challenges of incorporating AI as an educational tool, particularly in the context of student learning. The results of the study findings are expected to identify critical areas that need attention and help educators develop a deeper understanding of AI's impact on the educational field.

Conclusions:

By exploring the usability and efficacy of ChatGPT compared to standard online tools, this investigation seeks to inform educators and students on the responsible integration of AI into academic settings. Clinical Trial: NCT05963802


 Citation

Please cite as:

Veras M, Omer Dyer J, Rooney M, Barros Silva PG, Rutherford D, Kairy D

Usability and Efficacy of Artificial Intelligence Chatbots (ChatGPT) for Health Sciences Students: Protocol for a Crossover Randomized Controlled Trial

JMIR Res Protoc 2023;12:e51873

DOI: 10.2196/51873

PMID: 37999958

PMCID: 10709780

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.